The OncoScan somatic mutation panel was then used to analyze 64 specific mutations in nine cancer‐related genes (BRAF, KRAS, EGFR, IDH1, IDH2, PTEN, PIK3CA, NRAS, and TP53). This evidence concerns the gene KRAS and cancer.